HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sheehan, B. Articles by Saad, K. Search for Related Content PubMed Articles by Sheehan, B. Articles by Saad, K.

Service innovations: a dedicated drug treatment service for dementia

Division of Health in the Community, Medical School Building, University of Warwick, Coventry CV4 7AL, e-mail: B.Sheehan{at}warwick.ac.uk

Karim Saad, Consultant Old Age Psychiatrist

Coventry Teaching PCT, Caludon Centre, Coventry

Declaration of interest

B.S. has received support to attend a conference from Janssen-Cilag and Eisai. K.S. has received sponsorship from Shire, Janssen-Cilag, Eisai, Pfizer, Lundbeck and Novartis.

AIMS AND METHOD

To describe a targeted domiciliary drug treatment service for dementia and to establish clinical outcomes for its patients. All new referrals in a 6-month period were included. Data on clinical and demographic background, service performance and cognitive, functional and behavioural outcomes were recorded.

RESULTS

Of 96 patients initiated on antidementia drugs, most had dementia of mild to moderate severity, and had heterogenous diagnoses. Significant improvements in cognition, behaviour and function were found.

CLINICAL IMPLICATIONS

A dedicated domiciliary drug treatment service for dementia achieved high levels of clinical activity and outcomes at least as good as clinical trials. This service model may be an attractive choice.

This article has been cited by other articles:

				A. J Pelosi, S. V McNulty, and G. A Jackson Role of cholinesterase inhibitors in dementia care needs rethinking. BMJ, September 2, 2006; 333(7566): 491 - 493. [Full Text] [PDF]